← Russell 3000 cross-section

AORT ARTIVION, INC.

Trailing twelve months to 2026-06-30 · as filed 2026-08-07, not restated
Healthcare

Scale

Market cap
$1.3bn
Revenue TTM
$472m
Net income TTM
$-3m
Free cash flow
$-9m
Composite score
34.9
Sector rank
#1876

Valuation

P / E
EV / EBITDA
35.6
EV / sales
3.4
FCF yield
-0.69%
Earnings yield vs 10-yr
-4.97pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-0.7%
EBITDA margin
9.6%
ROE
-0.7%
ROIC
2.8%
Revenue growth
16.4%

Insider activity, last 90 days

Net open-market
$-3.00m
Buyers
0
Sellers
4

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We reported quarterly revenues of $125.8 million for the three months ended June 30, 2026, an 11% increase from the three months ended June 30, 2025. The increase in revenues for the three months ended June 30, 2026 was due to an increase in revenues from all products and preservation services other than surgical sealants, which remained relatively flat. Constant currency revenues, as defined below, increased 9% for the three months ended June 30, 2026, as compared to the three months ended June 30, 2025. …ARTIVION, INC., 10-Q, period ended 2026-06-30, filed 2026-08-07

Read the full passage →